Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study

Table 3

Correlations between sCD48 levels and type 2 biomarkers and evaluated inflammatory cytokines.

	sCD48 all volunteers	sCD48 in allergic asthma	sCD48 in nonallergic asthma	sCD48 in control
IL33 (pg/ml)	0.02 (−0.17–0.21),	−0.17 (−0.44–0.13),	0.09 (−0.33–0.48),	0.06 (−0.25–0.36),
IL17 (pg/ml)	0.09 (−0.09–0.27),	−0.19 (−0.46–0.09),	0.049 (−0.34–0.42),	0.09 (−0.19–0.36),
IFNγ (pg/ml)	0.21(−0.06–0.45),	−0.08 (−0.52–0.39),	0.41 (−0.05–0.73),	−0.19 (−0.60–0.30),
IgE (pg/ml)	0.06 (−0.13–0.25),	0.27 (−0.04–0.54),	−0.23 (−0.56–0.17),	−0.13 (−0.4–0.14),
Eos Abs (pg/ml)	0.11 (−0.07–0.28),	0.25 (−0.04–0.50),	−0.14 (−0.50–0.26),	0.03 (−0.24–0.31),
IL5 (pg/ml)	−0.04 (−0.24–0.16),	−0.08 (“-0.4–0.26),	0.30 (−0.10–0.62),	−0.3 (−0.57–0.03),

Data presented as Spearman correlation coefficients (IQR), value.